DASHARDRA WOODARD: Open Payments
NPI 1811436744 · MEMPHIS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$490 in 6 payments from 5 companies in 2025. Trend: 2023 $108 · 2024 $117 · 2025 $490
Food & beverage: $490
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 1 | $141 |
| AstraZeneca Pharmaceuticals LP | 1 | $120 |
| Novo Nordisk Inc | 1 | $113 |
| Lilly USA, LLC | 1 | $86 |
| Boston Scientific Corporation | 2 | $30 |
Products named: DEXCOM G7 GSS (161), BREZTRI, Wegovy, ZEPBOUND, Patient Trial Kit.
Industry payments across TN — which companies pay providers there.
